4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-22-050612
Chief Medical Officer acquired 612 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tada Hiroomi Chief Medical Officer | 2022-09-15 | Grant or award | +612 | $7.66 | $4,687 | 81,237 | D |
Loading xslF345X03/doc4.xml…